Bioactive compounds as an alternative for drug co-therapy: Overcoming challenges in cardiovascular disease prevention

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Critical reviews in food science and nutrition

• Publication date

  2018-04-13

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1080/10408398.2016.1235546PMID 27830947
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• US Food and Drug Administration

  2021cited by this paper
• Atherosclerosis.

  2020influential reference
• Statins for Primary Prevention of Cardiovascular Disease.

  2017cited by this paper
• Multiple anti-inflammatory and anti-atherosclerotic properties of red wine polyphenolic extracts: differential role of hydroxycinnamic acids, flavonols and stilbenes on endothelial inflammatory gene expression

  2016cited by this paper
• Green tea consumption and risk of cardiovascular and ischemic related diseases: A meta-analysis.

  2016cited by this paper
• Effects of phytosterols on markers of inflammation: A systematic review and meta-analysis.

  2016cited by this paper
• Lathosterol-to-cholesterol ratio in serum predicts cholesterol-lowering response to plant sterol consumption in a dual-center, randomized, single-blind placebo-controlled trial.

  2015cited by this paper
• The effect of plant sterols and different low doses of omega-3 fatty acids from fish oil on lipoprotein subclasses.

  2015cited by this paper
• Ezetimibe added to statin therapy after acute coronary syndromes

  2015cited by this paper
• Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

  2015cited by this paper
• Biomedical research: Drug hunters wanted

  2015cited by this paper
• Effects of extended-release niacin with laropiprant in high-risk patients.

  2014cited by this paper
• Reduction of low-density lipoprotein cholesterol by monoclonal antibody inhibition of PCSK9.

  2014cited by this paper
• Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

  2014cited by this paper
• Prediction of the functionality of young South American red wines based on chemical parameters

  2014cited by this paper
• Effect of plant sterols compared with ezetimibe on oxidative stress in patients treated with statins

  2014cited by this paper
• Overcoming toxicity and side-effects of lipid-lowering therapies.

  2014cited by this paper
• HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION

  2014influential reference
• LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges: a meta-analysis of randomised controlled studies

  2014cited by this paper
• Nutraceuticals and dyslipidaemia: Beyond the common therapeutics

  2014cited by this paper
• Low doses of eicosapentaenoic acid and docosahexaenoic acid from fish oil dose-dependently decrease serum triglyceride concentrations in the presence of plant sterols in hypercholesterolemic men and women.

  2014influential reference
• Resveratrol and cardiovascular health--promising therapeutic or hopeless illusion?

  2014influential reference
• Novel concepts in HDL pharmacology.

  2014cited by this paper
• Lipid lowering with PCSK9 inhibitors

  2014cited by this paper
• Niacin and HDL cholesterol--time to face facts.

  2014influential reference
• Top 10 cardiovascular therapies and interventions for the next decade

  2014influential reference
• Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease.

  2014cited by this paper
• Statins: Pleiotropic Regulators of Cardiovascular Redox State

  2014cited by this paper
• Epidemiological studies of CHD and the evolution of preventive cardiology

  2014influential reference
• The concept of the polypill in the prevention of cardiovascular disease.

  2014cited by this paper
• Targeting PCSK9 for hypercholesterolemia.

  2014cited by this paper
• Effects of resveratrol supplementation on plasma lipids: a systematic review and meta-analysis of randomized controlled trials.

  2013cited by this paper
• n-3 fatty acids in patients with multiple cardiovascular risk factors.

  2013cited by this paper
• Effect of red wines with different in vitro antioxidant activity on oxidative stress of high-fat diet rats.

  2013cited by this paper
• Lipid-Lowering Agents

  2013cited by this paper
• Impact of omega-3 fatty acids and/or plant sterol supplementation on non-HDL cholesterol levels of dyslipidemic Indian adults

  2013influential reference
• Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases

  2013cited by this paper
• Anti-atherosclerotic mechanisms of statin therapy.

  2013cited by this paper
• Statins in the primary prevention of cardiovascular disease

  2013cited by this paper
• Cardiovascular disease: Biochemistry to behaviour

  2013influential reference
• Statins and lipid metabolism: an update

  2013cited by this paper
• A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial).

  2013cited by this paper
• The role of fibrate treatment in dyslipidemia: an overview.

  2013cited by this paper
• Bioactive compounds in wine: Resveratrol, hydroxytyrosol and melatonin: A review

  2012influential reference
• Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction.

  2012cited by this paper
• Functional Foods and Nutraceuticals in the Primary Prevention of Cardiovascular Diseases

  2012cited by this paper
• Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: a randomized controlled trial[S]

  2012influential reference
• Long chain omega-3 fatty acids and cardiovascular disease: a systematic review

  2012cited by this paper
• Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work?

  2012influential reference
• Critical review: vegetables and fruit in the prevention of chronic diseases

  2012cited by this paper
• Phenolic compounds: from plants to foods

  2012cited by this paper
• Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.

  2012cited by this paper
• Chronic Ingestion of Flavan-3-ols and Isoflavones Improves Insulin Sensitivity and Lipoprotein Status and Attenuates Estimated 10-Year CVD Risk in Medicated Postmenopausal Women With Type 2 Diabetes

  2012cited by this paper
• Omega-3 fatty acids enhance monocyte-suppressing effect of bezafibrate in patients with isolated hypertriglyceridemia.

  2012influential reference
• Effects of plant sterols and stanols on intestinal cholesterol metabolism: suggested mechanisms from past to present.

  2012influential reference
• Universal screening and drug treatment of dyslipidemia in children and adolescents.

  2012cited by this paper
• The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability.

  2012cited by this paper
• Worldwide consumption of functional foods: a systematic review.

  2012cited by this paper
• n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

  2012cited by this paper
• Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial.

  2012cited by this paper
• Evolution of phenolic compounds from color and flavor problems to health benefits.

  2012influential reference
• Atherosclerosis: current pathogenesis and therapeutic options

  2011influential reference
• ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

  2011cited by this paper
• Tea and cancer prevention: epidemiological studies.

  2011cited by this paper
• Progress and challenges in translating the biology of atherosclerosis

  2011cited by this paper
• Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action.

  2011cited by this paper
• n-3 fatty acids in cardiovascular disease.

  2011cited by this paper
• Mechanistic issues concerning cancer prevention by tea catechins.

  2011influential reference
• Combined effects of ezetimibe and phytosterols on cholesterol metabolism: a randomized, controlled feeding study in humans.

  2011cited by this paper
• ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

  2011cited by this paper
• Effects of resveratrol and other wine polyphenols on vascular function: an update.

  2011cited by this paper
• Plant stanol esters lower LDL cholesterol level in statin-treated subjects with type 1 diabetes by interfering the absorption and synthesis of cholesterol.

  2011influential reference
• Statin myopathy: A common dilemma not reflected in clinical trials

  2011cited by this paper
• Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.

  2011cited by this paper
• ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

  2011cited by this paper
• Tea and cardiovascular disease.

  2011influential reference
• Pharmacological strategies for lowering LDL cholesterol: statins and beyond

  2011cited by this paper
• n-3 Fatty acids in cardiovascular disease.

  2011cited by this paper
• Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia.

  2011cited by this paper
• Resveratrol and cardiovascular health.

  2010cited by this paper
• Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk.

  2010cited by this paper
• Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids.

  2010cited by this paper
• High basal fractional cholesterol synthesis is associated with nonresponse of plasma LDL cholesterol to plant sterol therapy.

  2010cited by this paper
• n-3 fatty acids and cardiovascular events after myocardial infarction.

  2010cited by this paper
• N-3 polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: mechanisms and implications for obesity prevention.

  2010cited by this paper
• Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability.

  2010influential reference
• Oxidized LDL: Diversity, Patterns of Recognition, and Pathophysiology

  2010influential reference
• Support of drug therapy using functional foods and dietary supplements: focus on statin therapy

  2010cited by this paper
• HDL and LDL as therapeutic targets for cardiovascular disease prevention: the possible role of niacin.

  2010cited by this paper
• Resveratrol, obesity and diabetes.

  2010cited by this paper
• Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals.

  2009cited by this paper
• Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake.

  2009influential reference
• Beyond blood lipids: phytosterols, statins and omega-3 polyunsaturated fatty acid therapy for hyperlipidemia.

  2009cited by this paper
• Grapes, Wines, Resveratrol, and Heart Health

  2009cited by this paper
• Consumption of yerba mate ( Ilex paraguariensis ) improves serum lipid parameters in healthy dyslipidemic subjects and provides an additional LDL-cholesterol reduction in individuals on statin therapy.

  2009cited by this paper
• Prescription Omega-3 Fatty Acid as an Adjunct to Fenofibrate Therapy in Hypertriglyceridemic Subjects

  2009influential reference
• Dual biosynthetic pathways to phytosterol via cycloartenol and lanosterol in Arabidopsis

  2009cited by this paper
• The Effect of Adding Plant Sterols or Stanols to Statin Therapy in Hypercholesterolemic Patients: Systematic Review and Meta-Analysis

  2009cited by this paper
• Green Tea and Heart Health

  2009cited by this paper
• Green tea (Camellia sinensis) catechins and vascular function

  2009influential reference

• Flavonoids from the leaves of Monanthotaxis filipes modulate PCSK9 and LDLR

  2025cites this paper
• Relevance of Lipoprotein Composition in Endothelial Dysfunction and the Development of Hypertension

  2025cites this paper
• Investigating Ethanolic Extract from Acehnese Lime (Citrus aurantifolia) Peel as Potential Anti-Hypercholesterolemia Agent

  2024cites this paper
• Bioactive Compounds for Customized Brain Health: What Are We and Where Should We Be Heading?

  2023cites this paper
• Coupling food compounds data from FooDB and Phenol-Explorer to the Dutch food coding system NEVO: towards a novel approach to studying the role of food in health and disease

  2023cites this paper
• Efficacy of Bioactive Compounds in the Regulation of Metabolism and Pathophysiology in Cardiovascular Diseases

  2023cites this paper
• Protective mechanisms of a microbial oil against hypercholesterolemia: evidence from a zebrafish model

  2023cites this paper
• Valorisation of fruit waste for harnessing the bioactive compounds and its therapeutic application

  2023cites this paper
• Fisetin, a dietary flavonoid, promotes transintestinal cholesterol excretion through the activation of PPARδ.

  2023cites this paper
• Macrophage polarization by potential nutraceutical compounds: A strategic approach to counteract inflammation in atherosclerosis.

  2022cites this paper
• Bioactive compounds in functional food and their role as therapeutics

  2021cites this paper
• Natural bioactive compounds from fish

  2021cites this paper
• Atorvastatin reverses high cholesterol‐induced cardiac remodelling and regulates mitochondrial quality‐control in a cholesterol‐independent manner: An experimental study

  2021cites this paper
• Potential Benefits of Flavonoids on the Progression of Atherosclerosis by Their Effect on Vascular Smooth Muscle Excitability

  2021cites this paper
• Ipomea batatas Leaf Powder from Cameroon: Antioxidant Activity and Antihyperlipidemic Effect in Rats Fed with a High-Fat Diet

  2021cites this paper
• Investigating The Bioactive Properties of Cheese-Fruit Combinations Following In Vitro Digestion Using an Elderly Model.

  2021cites this paper
• Protective Effects of Individual and Combined Low Dose Beta-Carotene and Metformin Treatments against High-Fat Diet-Induced Responses in Mice

  2021influential citation
• Pathophysiology of atherosclerosis: Association of risk factors and treatment strategies using plant-based bioactive compounds.

  2020cites this paper
• Protective Effects of (E)-β-Caryophyllene (BCP) in Chronic Inflammation

  2020cites this paper
• Role of Oxidative Stress, Mitochondrial Dysfunction, and Autophagy in Cardiovascular Disease: Its Pathogenesis and Amelioration by Different Small Natural Molecules

  2019cites this paper
• Ensuring the future of functional foods

  2019cites this paper
• Classification of cowpea beans using multielemental fingerprinting combined with supervised learning

  2019cites this paper
• Cardiovascular Disease Prevention: The Earlier the Better? A Review of Plant Sterol Metabolism and Implications of Childhood Supplementation

  2019cites this paper
• The natural phenolic compounds as modulators of NADPH oxidases in hypertension.

  2019cites this paper
• Microfluidization trends in the development of nanodelivery systems and applications in chronic disease treatments

  2018cites this paper
• Agrobiotechnology Goes Wild: Ancient Local Varieties as Sources of Bioactives

  2018cites this paper
• Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases

  2018cites this paper
• Comparison between red wine and isolated trans-resveratrol on the prevention and regression of atherosclerosis in LDLr (-/-) mice.

  2018cites this paper
• Statin dose reduction with complementary diet therapy: A pilot study of personalized medicine

  2018cites this paper
• Combined bioactive approach over atherosclerosis risk biomarkers

  2017cites this paper